IFN-β treatment modulates the CD28/CTLA-4-mediated pathway for IL-2 production in patients with relapsing-remiting multiple sclerosis

  1. Espejo, C.
  2. Brieva, L.
  3. Ruggiero, G.
  4. Río, J.
  5. Montalban, X.
  6. Martínez-Cáceres, E.M.
Journal:
Multiple Sclerosis

ISSN: 1352-4585

Year of publication: 2004

Volume: 10

Issue: 6

Pages: 630-635

Type: Article

DOI: 10.1191/1352458504MS1094OA GOOGLE SCHOLAR

Sustainable development goals

Data source: Scopus